Click this link for the previous article in our Hartz “Executive Summary” exposé: Fun with Charts!
We have challenged Hartz’ claims of being committed to providing factual information and also shed some light on the false nature of their charts.
Now we’re ready to tackle a brazen lie Hartz makes in their infamous Executive Summary of EPA Evaluation of Pet Spot On Products. Page 5, Paragraph 1, Sentence 3:
“Frontline® and Advantage® are NOT prescription products nor are they registered with the FDA.”
This is inaccurate, but first additional information and clarification is necessary.
Prior to our Broken Hartz affiliates’ email to the distributor involved in this case Rite Aid Corporation, on 1/21/12, they had found some resources citing Frontline as being FDA approved. We are unable to substantiate Frontline’s FDA status. Since the product recommended by the Broken Hartz affiliates’ Vet was Advantage, we see no harm in removing Frontline from the equation.
Moving on, we have seen this argument from Hartz before. They try to confuse the public, using the fact not all Advantage products are FDA approved. We will not bother listing every product in the Advantage family that has received the distinction of being FDA approved to point out the false nature of Hartz’ statement, but it’s appropriate to list:
ADVANTAGE MULTI for Cats: NADA 141-254 (Active Ingredients: imidacloprid and moxidectin)
– Approval Document
ADVANTAGE MULTI for Dogs: NADA 141-251 (Active Ingredients: imidacloprid and moxidectin)
– Approval Document

This is a screen capture from the FDA’s PowerPoint titled “What You Need to Know: Approved vs. Unapproved Animal Drugs”.
Actually, Advantage isn’t the only flea control product line to have FDA approved products. Here are some more examples of FDA approved flea control products:
Pro-Spot Solution: NADA 132-789 (Active Ingredient: Fenthion)
Program Suspension: NADA 141-026 (Active Ingredient: Lufenron)
Revolution: NADA 141-152 (Active Ingredient:Selamectin)
These FDA approved products are indicated for the treatment of flea infestations and are administered in an identical procedure to Hartz spot-on products.
As it turns out, Hartz was being modest! They refrained from mentioning they have a flea control product on the FDA website, too:
Hartz Flea Control Capsules AKA Zodiac Fleatrol Caps: NADA 141-162 (Active Ingredient:S-methoprene)
Additionally, the Hartz product has a distinction on its page that none of the others do:
We guess there was a problem. It’s odd, because as an (s-)methoprene only product, this wouldn’t make sense unless, of course, there’s something questionable in the “secret sauce”.
These products and more can be found by searching the Animal Drugs portion of the FDA’s website.
Additionally, Hartz seems to be confused about the finer points of FDA terminology. “Registered with the FDA” does not mean the same thing as “Approved by the FDA”. Many products are “registered” with the FDA, while not all receive approval.
Again, the above linked products, with one notable exception, are approved by the FDA. Furthermore, these products have been FDA approved for years.
More information from the FDA regarding vital differences between FDA-Approved and Unapproved Animal Drugs can be found here.
Please Note: No members of Broken Hartz are Veterinarians. Please speak with a reputable Vet before using any product on your animal(s).
More to come.
Click this link for the next article in our Hartz “Executive Summary” exposé: Rite Aid Corporation Still in Bed with Hartz
























